Clomiphene citrate treatment for late onset hypogonadism: rise and fall

ABSTRACT Objective: Previous series have demonstrated that Clomiphene Citrate (CC) is an effective treatment to increase Total Testosterone (TT) in Late Onset Hypogonadism (LOH) patients. However, what happens to TT levels after ending CC treatment is still debatable. The objective of this study is to evaluate TT levels 3 months after the discontinuation of CC in patients with LOH who were previously successfully treated with the same drug. Materials and Methods: Twenty-seven patients with LOH that were successfully treated (achieved TT levels >11nmol/l) with CC 50mgs daily for 50 days were prospectively recruited in our Andrological outpatient clinic. CC was then stopped for 3 months and TT levels were measured at the end of this period. Results: Mean TT level before discontinuation of CC was 22.7±8.1nmol/L (mean±SD). Three months after discontinuation, mean TT level significantly decreased in all patients, 10.2±3.9nmol/l (p<0.01). Twenty-one patients (78%) decreased TT levels under 11nmol/L. Six patients (22%) had TT levels that remained within the normal recommended range (≥11nmol/l). No statistical significant differences were observed between both groups. Conclusion: In the short term LOH does not seem to be a reversible condition in most patients after CC treatment. More studies with longer follow-up are needed to evaluate the kinetics of TT in LOH.

Saved in:
Bibliographic Details
Main Authors: Marconi,Marcelo, Souper,Renato, Hartmann,Jonathan, Alvarez,Matías, Fuentes,Ignacio, Guarda,Francisco J.
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Urologia 2016
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382016000601190
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1677-55382016000601190
record_format ojs
spelling oai:scielo:S1677-553820160006011902016-11-22Clomiphene citrate treatment for late onset hypogonadism: rise and fallMarconi,MarceloSouper,RenatoHartmann,JonathanAlvarez,MatíasFuentes,IgnacioGuarda,Francisco J. Hypogonadism Clomiphene Testosterone Therapeutics ABSTRACT Objective: Previous series have demonstrated that Clomiphene Citrate (CC) is an effective treatment to increase Total Testosterone (TT) in Late Onset Hypogonadism (LOH) patients. However, what happens to TT levels after ending CC treatment is still debatable. The objective of this study is to evaluate TT levels 3 months after the discontinuation of CC in patients with LOH who were previously successfully treated with the same drug. Materials and Methods: Twenty-seven patients with LOH that were successfully treated (achieved TT levels >11nmol/l) with CC 50mgs daily for 50 days were prospectively recruited in our Andrological outpatient clinic. CC was then stopped for 3 months and TT levels were measured at the end of this period. Results: Mean TT level before discontinuation of CC was 22.7±8.1nmol/L (mean±SD). Three months after discontinuation, mean TT level significantly decreased in all patients, 10.2±3.9nmol/l (p<0.01). Twenty-one patients (78%) decreased TT levels under 11nmol/L. Six patients (22%) had TT levels that remained within the normal recommended range (≥11nmol/l). No statistical significant differences were observed between both groups. Conclusion: In the short term LOH does not seem to be a reversible condition in most patients after CC treatment. More studies with longer follow-up are needed to evaluate the kinetics of TT in LOH.info:eu-repo/semantics/openAccessSociedade Brasileira de UrologiaInternational braz j urol v.42 n.6 20162016-12-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382016000601190en10.1590/s1677-5538.ibju.2016.0112
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Marconi,Marcelo
Souper,Renato
Hartmann,Jonathan
Alvarez,Matías
Fuentes,Ignacio
Guarda,Francisco J.
spellingShingle Marconi,Marcelo
Souper,Renato
Hartmann,Jonathan
Alvarez,Matías
Fuentes,Ignacio
Guarda,Francisco J.
Clomiphene citrate treatment for late onset hypogonadism: rise and fall
author_facet Marconi,Marcelo
Souper,Renato
Hartmann,Jonathan
Alvarez,Matías
Fuentes,Ignacio
Guarda,Francisco J.
author_sort Marconi,Marcelo
title Clomiphene citrate treatment for late onset hypogonadism: rise and fall
title_short Clomiphene citrate treatment for late onset hypogonadism: rise and fall
title_full Clomiphene citrate treatment for late onset hypogonadism: rise and fall
title_fullStr Clomiphene citrate treatment for late onset hypogonadism: rise and fall
title_full_unstemmed Clomiphene citrate treatment for late onset hypogonadism: rise and fall
title_sort clomiphene citrate treatment for late onset hypogonadism: rise and fall
description ABSTRACT Objective: Previous series have demonstrated that Clomiphene Citrate (CC) is an effective treatment to increase Total Testosterone (TT) in Late Onset Hypogonadism (LOH) patients. However, what happens to TT levels after ending CC treatment is still debatable. The objective of this study is to evaluate TT levels 3 months after the discontinuation of CC in patients with LOH who were previously successfully treated with the same drug. Materials and Methods: Twenty-seven patients with LOH that were successfully treated (achieved TT levels >11nmol/l) with CC 50mgs daily for 50 days were prospectively recruited in our Andrological outpatient clinic. CC was then stopped for 3 months and TT levels were measured at the end of this period. Results: Mean TT level before discontinuation of CC was 22.7±8.1nmol/L (mean±SD). Three months after discontinuation, mean TT level significantly decreased in all patients, 10.2±3.9nmol/l (p<0.01). Twenty-one patients (78%) decreased TT levels under 11nmol/L. Six patients (22%) had TT levels that remained within the normal recommended range (≥11nmol/l). No statistical significant differences were observed between both groups. Conclusion: In the short term LOH does not seem to be a reversible condition in most patients after CC treatment. More studies with longer follow-up are needed to evaluate the kinetics of TT in LOH.
publisher Sociedade Brasileira de Urologia
publishDate 2016
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382016000601190
work_keys_str_mv AT marconimarcelo clomiphenecitratetreatmentforlateonsethypogonadismriseandfall
AT souperrenato clomiphenecitratetreatmentforlateonsethypogonadismriseandfall
AT hartmannjonathan clomiphenecitratetreatmentforlateonsethypogonadismriseandfall
AT alvarezmatias clomiphenecitratetreatmentforlateonsethypogonadismriseandfall
AT fuentesignacio clomiphenecitratetreatmentforlateonsethypogonadismriseandfall
AT guardafranciscoj clomiphenecitratetreatmentforlateonsethypogonadismriseandfall
_version_ 1756428215260282880